IJRR

International Journal of Research and Review

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Year: 2025 | Month: January | Volume: 12 | Issue: 1 | Pages: 247-251

DOI: https://doi.org/10.52403/ijrr.20250131

Analysis of Prescription Pattern of Drugs Among Oncology Patients in a Tertiary Care Teaching Hospital

Dr. Sabarinath H1, Fiyona K George1, Sonatta Monica Jose1, Josmi James2, Sherin V Kurian3

1,2,3Bapuji Pharmacy College, Davanagere, Karnataka, India

Corresponding Author: Dr. Sabarinath H

ABSTRACT

Cancer demands a timely diagnosis and proper management for a better clinical outcome. There are many anti-neoplastic agents and regimens available for the treatment of cancer, with variable response rates and adverse drug reactions (ADRs). So the proper selection of anti-neoplastic drugs and treatment regimens are crucial to ensure a better prognosis. The main objectives of the study were to analyze the prescription pattern among cancer patients and to identify the presence of external risk factors among them. A prospective, cross – sectional and descriptive study was conducted among 100 cancer patients for a period of 6 months. The data collected were analyzed for evaluating the prescription pattern and to identify the external risk factors that might have led to the development of different types of cancers. Among the patients involved in the study, 32 were male and 68 were female and majority of the patients belonged to the age group of 31-75 years. Risk factors like smoking, alcohol, tobacco and betel nut were identified among the patients. An assessment of relationship between risk factors and various types of cancers was performed which demonstrated a significant association between lung cancer and smoking. It was also found that smoking and alcohol consumption was related to esophageal cancer. The most commonly used antineoplastic agents were cyclophosphamide, Doxorubicin, 5-Fluorouracil and paclitaxel. Agents like Proton pump inhibitors, anti-emetics and analgesics were also used among the patients as pre-medications and adjuvant drugs to prevent and treat ADRs associated with the use of antineoplastic drugs.

Keywords: Cancer, Chemotherapy, Antineoplastic agents, Risk factors

[PDF Full Text]